Klinicky signifikantní diabetický makulární edém: pars plana vitrektomie či laserová koagulace?

Kód výsledku v IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216224%3A14110%2F07%3A00024060" target="_blank" >RIV/00216224:14110/07:00024060 - isvavai.cz</a>

Výsledek na webu

—

DOI - Digital Object Identifier

—

Jazyk výsledku

angličtina

Název v původním jazyce

Clinically significant diabetic macular oedema (CSME): pars plana vitrectomy or laser coagulation?

Popis výsledku v původním jazyce

Purpose: compare results of PPV with peeling ILM to classical laser coagulation Method: 20 patients with CSME were randomizing into two groups. Group one was treated by pars plana vitrectomy with peeling of ILM, group two was treated by focal and panretinal laser coagulation. The anatomical healing was proofed by slit lamp biomicroscopy and OCT examination. Exclusion criteria were previous PPV, epiretinal membrane or proliferative diabetic retinopathy, hard exudates, previous laser therapy, glaucoma andintravitreal injection of triamcinolon or antiVEGF agent. Examinations were done in 1 month, 3 month and 1 year. Results: Median duration of CSME at the time of PPV was approximately 11.0 months. The median preoperative best-corrected VA of 0.08, improved to a median postoperative VA of 0.25. 10 eyes without preoperative laser coagulation had a median VA improvement of 77%, while 10 eyes with preoperative macular laser treatment had a median VA improvement of 14.8%. In all 20 eyes, CSME

Název v anglickém jazyce

Clinically significant diabetic macular oedema (CSME): pars plana vitrectomy or laser coagulation?

Popis výsledku anglicky

Purpose: compare results of PPV with peeling ILM to classical laser coagulation Method: 20 patients with CSME were randomizing into two groups. Group one was treated by pars plana vitrectomy with peeling of ILM, group two was treated by focal and panretinal laser coagulation. The anatomical healing was proofed by slit lamp biomicroscopy and OCT examination. Exclusion criteria were previous PPV, epiretinal membrane or proliferative diabetic retinopathy, hard exudates, previous laser therapy, glaucoma andintravitreal injection of triamcinolon or antiVEGF agent. Examinations were done in 1 month, 3 month and 1 year. Results: Median duration of CSME at the time of PPV was approximately 11.0 months. The median preoperative best-corrected VA of 0.08, improved to a median postoperative VA of 0.25. 10 eyes without preoperative laser coagulation had a median VA improvement of 77%, while 10 eyes with preoperative macular laser treatment had a median VA improvement of 14.8%. In all 20 eyes, CSME

Druh

D - Stať ve sborníku

CEP obor

FF - ORL, oftalmologie, stomatologie

OECD FORD obor

—

Projekt

<a href="/cs/project/NR8369" target="_blank" >NR8369: Ultrastruktura vitreoretinálního rozhraní u diabetického makulárního edému</a><br>

Návaznosti

P - Projekt vyzkumu a vyvoje financovany z verejnych zdroju (s odkazem do CEP)

Rok uplatnění

2007

Kód důvěrnosti údajů

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Název statě ve sborníku

Supplement European Journal of Ophthalomology

ISBN

—

ISSN

1120-6721

e-ISSN

—

Počet stran výsledku

1

Strana od-do

—

Název nakladatele

Wichtig Editore Medical Publisher

Místo vydání

Vienna

Místo konání akce

Vienna

Datum konání akce

1. 1. 2007

Typ akce podle státní příslušnosti

WRD - Celosvětová akce

Kód UT WoS článku

—